Viewing data from:

ADENOSINE

ANDA

ADENOSINE | A203883 | HOSPIRA INC

2 strengths0 unique patents0 unique exclusivities

Hatch-Waxman Litigation

1 case on OB patents from PACER

Case	Court	Filed	Status	Judge
Astellas US LLC et al v. Hospira Inc. 1:2012cv00652 1 patentANDA 203883adenosine	D. Del.	2012-05-23	Terminated 2012-09-27	—

Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).

API Supply Chain9 active DMFs10 inactive

8 active API suppliers hold Drug Master Files for this ingredient.

PHARMA-WALDHOF GMBHADENOSINE

DMF 77281988

ZHEJIANG HISUN PHARMACEUTICAL CO LTDADENOSINE USP

DMF 173062004

WOCKHARDT LTDADENOSINE USP

DMF 200712007

EUTICALS SPAADENOSINE

DMF 222322008

EMCURE PHARMACEUTICALS LTDADENOSINE USP

DMF 338712019

JIANGSU SYNTHGENE BIOTECHNOLOGY CO LTDADENOSINE TRIPHOSPHATE

DMF 377722022

GUANGXI MINGJIAN PHARMACEUTICAL CO LTDADENOSINE TRIPHOSPHATE DISODIUM

DMF 386132023

JIANGSU SYNTHGENE BIOTECHNOLOGY CO LTDADENOSINE TRIPHOSPHATE (ATP) TRIS SOLUTION

DMF 396152024

JOYANG LABORATORIESADENOSINE

DMF 406312024

BECTON DICKINSON AND COInactiveADENOSINE CYCLIC PHOSPHATE MANUF. BY SCHWARZ BIORESEARCH

DMF 12691968

SIGMA F AND D DIV LTDInactiveADENOSINE 5' TRIPHOSPHATE (ATP) DISODIUM SALT

DMF 48421983

ROCHE DIAGNOSTICS GMBHInactiveADENOSINE DEAMINASE THERAPEUTIC GRADE

DMF 82251989

KV PHARMACEUTICAL COInactiveADENOSINE SUBLINGUAL TABLETS, 25 MG.

DMF 86771990

KYOWA HAKKO KOGYO CO LTDInactiveADENOSINE

DMF 88281990

KYOWA HAKKO KOGYO CO LTDInactiveADENOSINE TRIPHOSPHATE DISODIUM

DMF 95691992

YAMASA SHOYU CO LTDInactiveADENOSINE

DMF 97771992

RELIABLE BIOPHARMACEUTICAL LLCInactiveADENOSINE

DMF 159002002

AJINOMOTO CO INCInactiveADENOSINE

DMF 176212004

DALIAN ZHEN AO BIO TECH CO LTDInactiveADENOSINE 5' -MONOPHOSPHATE FREE ACID

DMF 231542009

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 60MG/20ML (3MG/ML)

0 patents0 exclusivities▴

SOLUTION;INTRAVENOUS | Approved: Mar 24, 2014

No patent or exclusivity listings for this strength.

#002 — 90MG/30ML (3MG/ML)

0 patents0 exclusivities▾

SOLUTION;INTRAVENOUS | Approved: Mar 24, 2014